Literature DB >> 21947727

Single-port versus multi-port cholecystectomy for patients with acute cholecystitis: a retrospective comparative analysis.

Dietmar Jacob1, Roland Raakow.   

Abstract

BACKGROUND: Trans-umbilical single-port laparoscopic cholecystectomy for chronic gallbladder disease is becoming increasingly accepted worldwide. But so far, no reports exist about the challenging single-port surgery for acute cholecystitis. The objective of this study was to describe our experience with single-port cholecystectomy in comparison to the conventional laparoscopic technique.
METHODS: Between August 2008 and March 2010, 73 patients with symptomatic gallbladder disease and histopathological signs of acute cholecystitis underwent laparoscopic cholecystectomy at our institution. Thirty-six patients were operated on with the single-port technique (SP group) and the data were compared with a control group of 37 patients who were treated with the multi-port technique (MP group).
RESULTS: The mean age in the SP group was 61.5 (range 21-81) years and in the MP group was 60 (range 21-94) (P=0.712). Gender, ASA status and BMI were not significantly different. The number of white blood cells was different before [SP: 9.2 (range 2.8-78.4); MP: 13.2 (range 4.4-28.6); P=0.001] and after the operation [SP: 7.8 (range 3.5-184.8); MP: 11.1 (range 5-20.8); P=0.002]. Mean operating time was 88 (range 34-174) minutes in the SP group vs 94 (range 39-209) minutes in the MP group (P=0.147). Four patients (5%) required conversion to an open procedure (SP: 1; MP: 3; P=0.320). During the follow-up period of 332 (range 29-570) days in the SP group and 428 (range 111-619) days in the MP group (P=0.044), eleven (15%) patients developed postoperative complications (P=0.745) and two patients in the SP group required reoperation (P=0.154).
CONCLUSIONS: Trans-umbilical single-port cholecystectomy for beginning acute cholecystitis is feasible and the complication rate is comparable with the standard multi-port operation. In spite of our good results, these operations are difficult to perform and should only be done in high-volume centers for laparoscopic surgery with experience in single-port surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21947727     DOI: 10.1016/s1499-3872(11)60088-x

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  8 in total

1.  The role and validity of surgical simulation.

Authors:  Riaz A Agha; Alexander J Fowler
Journal:  Int Surg       Date:  2015-02

2.  A Comparative Study of Single Incision versus Conventional Four Ports Laparoscopic Cholecystectomy.

Authors:  Ranendra Hajong; Debobratta Hajong; Tanie Natung; Madhur Anand; Girish Sharma
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  Risk factors for a prolonged operative time in a single-incision laparoscopic cholecystectomy.

Authors:  Norihiro Sato; Kei Yabuki; Kazunori Shibao; Yasuhisa Mori; Toshihisa Tamura; Aiichiro Higure; Koji Yamaguchi
Journal:  HPB (Oxford)       Date:  2013-04-04       Impact factor: 3.647

Review 4.  Remains of the day: biliary complications related to single-port laparoscopic cholecystectomy.

Authors:  Pierre Allemann; Nicolas Demartines; Markus Schäfer
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 5.  Single-incision laparoscopic cholecystectomy: a systematic review of methodology and outcomes.

Authors:  Masato Yamazaki; Hideki Yasuda; Keiji Koda
Journal:  Surg Today       Date:  2014-05-22       Impact factor: 2.549

Review 6.  The role of non-technical skills in surgery.

Authors:  Riaz A Agha; Alexander J Fowler; Nick Sevdalis
Journal:  Ann Med Surg (Lond)       Date:  2015-10-09

7.  Single-Port Cholecystectomy for Cholecystitis Versus Non-Cholecystitis.

Authors:  Marco Casaccia; Marta Ponzano; Tommaso Testa; Sofia Paola Martigli; Cecilia Contratto; Franco De Cian
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

8.  The First Additional Port During Single-Incision Laparoscopic Cholecystectomy.

Authors:  Ju-Hee Lee; Gangmi Kim
Journal:  JSLS       Date:  2020 Apr-Jun       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.